🇺🇸 Alphalipoic acid in United States

30 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 30

Most-reported reactions

1. Dizziness — 4 reports (13.33%)
2. Insomnia — 4 reports (13.33%)
3. Blood Pressure Increased — 3 reports (10%)
4. Flushing — 3 reports (10%)
5. Headache — 3 reports (10%)
6. Nausea — 3 reports (10%)
7. Neuropathy Peripheral — 3 reports (10%)
8. Pain In Extremity — 3 reports (10%)
9. Arthralgia — 2 reports (6.67%)
10. Asthenia — 2 reports (6.67%)

Source database →

Frequently asked questions

Is Alphalipoic acid approved in United States?

Alphalipoic acid does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Alphalipoic acid in United States?

All India Institute of Medical Sciences, Bhubaneswar is the originator. The local marketing authorisation holder may differ — check the official source linked above.